Pancreatic Cancer UK welcomes the launch of a new trial for patients with advanced pancreatic cancer in the UK. The trial investigates the use of IMM-101, a type of immunotherapy treatment, to treat pancreatic cancer. Treatment options for pancreatic cancer patients are limited and particularly so for advanced disease. Pancreatic Cancer UK believes that research like this may offer patients more hope for a better quality of life.
New UK trial for advanced pancreatic cancer patients
Posted by: 27 July 2011